The KCNC1 Gene Epilepsy Progressive Myoclonic Type 7 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the KCNC1 gene that are associated with Progressive Myoclonic Epilepsy Type 7 (EPM7). This condition is a rare neurological disorder characterized by a combination of myoclonus (sudden, involuntary muscle jerks) and seizures, alongside other potential symptoms such as cognitive decline and ataxia. The test plays a crucial role in the accurate diagnosis and management of the disorder, allowing for targeted therapeutic strategies and genetic counseling for affected families.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and examining it for specific genetic alterations in the KCNC1 gene. These mutations disrupt the normal function of Kv3.1, a protein essential for the rapid firing of neurons, leading to the symptoms observed in EPM7.

The cost of the KCNC1 Gene Epilepsy Progressive Myoclonic Type 7 Genetic Test is 4400 AED. Given the complexity of genetic testing and the specialized analysis involved, this cost reflects the comprehensive approach taken by DNA Labs UAE to ensure accurate and reliable results. For patients and families facing the challenges of Progressive Myoclonic Epilepsy Type 7, this test offers a valuable resource for diagnosis and future planning.